Back

Diagnostic value of subendocardial viability ratio in assessing coronary microvascular function in patients with non-obstructive coronary artery disease

29 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: invasive and non-invasive diagnostics (1) Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Haotai Xie

Beijing (China)

5 More presentations in this session

Presentation thumbnail
Prognostic impact of Flow-Mediated Dilation (FMD) in plaque rupture and plaque erosion
Doctor Y. Ishii (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Plasma proteomics identifies immune pathways associated with impaired coronary flow reserve in ANOCA patients
Ms E. De Jong (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Reversible perfusion defect in myocardial scintigraphy in coronary artery aneurysm or ectasia
Doctor K. Stepien (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The diagnostic performance of EST in identifying CMD in patients with ANOCA: insights into endotypes and clinical implications
Doctor A. Aldujeli (Co. Limerick, IE)
Abstract Slides Video
Presentation thumbnail
Association between abdominal fat distribution, coronary artery calcium score, and all-cause mortality: data from a large cohort of patients submitted to cardiac CT scan
Miss C. Costa (Viana Do Castelo, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: invasive and non-invasive diagnostics (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Session
Non-obstructive coronary disease: what's new in assessment and management
thumbnail
Congress Session
Microvascular dysfunction: optimising diagnosis and prognosis
thumbnail
Congress Presentation
Association between subendocardial viability ratio and cardiovascular events: a cohort study in a Chinese community-based population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources